Medically reviewed by Dr Zeeshan Afzal (MBBS, General Practitioner) — Medical Content Reviewer, Welzo.
Written by: The Welzo Longevity Editorial Team | Last updated: July 2026
Declared interest: Welzo sells both forms, including ubiquinol. This comparison is unusual in that key studies on both sides were funded by companies selling one form or the other. We have named who funded what throughout. See our editorial policy.
Walk into any health shop and you will find ubiquinol priced at roughly double conventional CoQ10, with packaging implying obvious superiority. The argument is simple: ubiquinol is the active, reduced, better-absorbed form, and ubiquinone is the outdated cheap one.
The evidence is more interesting than that, and we grade it here on the same basis as our longevity supplements guide and the rest of the anti-ageing and longevity supplements range: what the outcome trials actually used, not what the packaging claims.
That is the same test we applied to NAD⁺ precursors in NMN benefits, side effects and dosage, the NMN supplements range and NMN Pro 1000, and it determines where CoQ10 belongs in a longevity stack.
There is real pharmacokinetic data supporting ubiquinol — and there is equally real data showing that a well-made ubiquinone outperforms a poorly-made ubiquinol, that your body converts between the two forms during absorption anyway, and that every major clinical outcome trial was run on the cheaper form.
The short answer
Formulation matters more than form. Around 90% of circulating CoQ10 appears in the reduced ubiquinol form regardless of which you swallow, because conversion happens during digestion and absorption [1]. Head-to-head work found that carrier lipid and solubilisation drive bioavailability more than redox form, with a solubilised ubiquinone softgel out-absorbing an oil-based ubiquinol softgel [1,2]. Ubiquinol does show advantages in some studies, particularly in adults over 60 [6,7]. But an independent review of 28 randomised trials recommended ubiquinone for cardiovascular outcomes [3] — and that is the form the outcome trials actually used. For most people under 60, a well-formulated ubiquinone softgel at an adequate dose is the better buy.
Table of contents
Coenzyme Q10 is a fat-soluble compound found in all human cell membranes, essential to mitochondrial energy production — particularly in organs with high metabolic demand such as the heart, kidneys and liver [1].
It exists in two interconvertible forms:
The word doing the heavy lifting there is interconvertible. These are not two different substances. They are two oxidation states of the same molecule, and your body moves between them continuously as part of normal mitochondrial function.
CoQ10 is highly lipophilic and requires micellarisation with dietary fat for intestinal uptake, is transported via chylomicrons through the lymphatic system, and undergoes significant first-pass hepatic metabolism. Regardless of form, oral CoQ10 bioavailability is estimated at just 1–8% of the administered dose under standard conditions [1].
That number matters. Both forms are poorly absorbed. Arguing about which is marginally less poorly absorbed misses that how the product is formulated — and whether you take it with fat — may swamp the difference.
The marketing argument has a genuinely appealing logic. It runs: ubiquinol is the biologically active form, your body has to convert ubiquinone into it, that conversion becomes less efficient with age, so skip the step and take the active form directly.
Every clause in that chain is individually defensible. The problem is the conclusion, because two things it omits change the arithmetic considerably: your body converts in both directions during digestion, and the form on the label is not the dominant variable in whether the compound reaches your bloodstream. We deal with both below.
This structure — a chain of true statements producing an overstated conclusion — recurs throughout the supplement category. It is the same shape as the sirtuin argument for resveratrol, which we examine in does resveratrol actually work?
Here is the single most important finding in this debate, and it is rarely mentioned on ubiquinol packaging.
Research has found that approximately 90% of circulating CoQ10 appears in the reduced ubiquinol form regardless of whether ubiquinone or ubiquinol was consumed, reflecting conversion during digestion and absorption [1].
Swallow ubiquinone and your body reduces it to ubiquinol on the way in. Your plasma ends up looking much the same either way.
Ubiquinol is chemically unstable and readily oxidises back to ubiquinone. This is not merely theoretical: a laboratory investigation examined 13 ubiquinol products marketed in the United States and measured the extent to which their ubiquinol content had already converted to ubiquinone [5].
So the premium form may partially convert to the cheap form before you even swallow it, or in your stomach, while the cheap form converts to the premium form during absorption. The redox state you paid for is not reliably the redox state that arrives.
What this does and does not mean: it does not mean ubiquinol is useless — the absorption data below is real. It means the intuitive argument ("take the active form directly") is weaker than it sounds, because the body was always going to handle the conversion. This is the same reasoning we applied to NAC and glutathione in NAC for healthy ageing.
There is genuine data here and it should not be dismissed:
Now the findings that complicate the picture considerably:
Mantle and Dybring's review makes one finding stand out above all the others in this debate. The dispersion of CoQ10 crystals in the initial formulation is critical — and its absence reduces bioavailability by 75% [1].
Set that against the differences being argued over between redox forms. A manufacturing detail most consumers have never heard of, and which appears nowhere on any label, swamps the variable the entire premium is charged for.
Read the evidence together and a different explanation emerges: much of ubiquinol's apparent advantage in earlier studies may reflect better dissolution and micellarisation of the amorphous ubiquinol form compared with poorly-dissolving crystalline ubiquinone — a formulation difference, not an inherent redox advantage [1,2].
This is one of the few supplement comparisons where the conflicts run in both directions, and readers deserve the map.
| Source | Finding | Commercial position |
|---|---|---|
| Hosoe et al. 2007 and related Kaneka-funded absorption work | Ubiquinol absorbs better | Kaneka manufactures both pharmaceutical-grade ubiquinone and ubiquinol [4] |
| Mantle & Dybring 2020 | Ubiquinol superiority "would appear to be mistaken" | Both authors employed by Pharma Nord, which makes the ubiquinone product used in major trials [1] |
| López-Lluch et al. 2019, seven-formulation crossover | Carrier lipid and solubilisation matter more than redox form | Independent academic group [2] |
| Fladerer & Grollitsch 2023, review of 28 RCTs | Recommends ubiquinone for cardiovascular outcomes | Independent review [3] |
The pattern is instructive. The strongest pro-ubiquinol absorption data comes substantially from a manufacturer that sells both forms; the strongest anti-ubiquinol argument comes from a competitor selling ubiquinone. The most useful evidence is the independent work — and that points at formulation rather than form.
We apply the same test throughout this series, whether to competitor-funded NMN testing in is NMN a scam? or industry-funded collagen trials in supporting skin ageing from the inside.
Absorption is a surrogate marker. What matters is whether people get better.
An independent review of 28 randomised controlled trials recommended ubiquinone over ubiquinol for cardiovascular outcomes [3]. That is not a statement about absorption — it is a statement about the weight of clinical evidence.
The reason is straightforward: the major cardiovascular outcome research, including the heart failure trials most often cited for CoQ10, was conducted using ubiquinone formulations [1]. Ubiquinol's own trial base consists largely of absorption and fertility studies, with fewer hard clinical endpoints [6].
The practical implication: if your reason for taking CoQ10 is heart health, migraine prevention or statin-associated muscle symptoms, the clinical evidence base for those uses was built with ubiquinone. Buying the premium form means buying the form with less outcome evidence behind it for the thing you actually want.
There is one notable ubiquinol outcome trial worth acknowledging: a multicentre, randomised, double-blind, placebo-controlled phase 2 study of high-dose ubiquinol (1,500 mg/day) in multiple system atrophy found it was well tolerated and produced a significantly smaller decline in disease rating scores than placebo [6]. That is a specific neurological condition, not general use.
If there is a legitimate case for the premium, it is here.
The enzymatic reduction of ubiquinone to ubiquinol depends on reductase activity, which declines with age. The pro-ubiquinol studies showing the largest advantages were conducted specifically in older populations — the 4.3-fold AUC difference was in adults over 60 [6], and the roughly two-fold plasma difference reported elsewhere was in adults aged 65 and over [6].
That is mechanistically coherent: if your capacity to convert is reduced, supplying the converted form may help more.
Those comparisons still typically pitted ubiquinol against standard rather than optimised ubiquinone formulations, so some of the gap may again be formulation rather than form [1,2]. The age argument is the strongest one ubiquinol has, and it is still not clean.
Based on the formulation research, these matter more than choosing ubiquinol over ubiquinone:
Before choosing a form, it is worth being clear about what you are choosing it for — because CoQ10's evidence is concentrated in specific clinical contexts rather than in general healthy ageing.
| Use | Evidence status | Form used in the research |
|---|---|---|
| Heart failure | The strongest area; supported by randomised outcome trials | Ubiquinone [1,3] |
| Statin-associated muscle symptoms | Mixed and debated | Mostly ubiquinone |
| Migraine prevention | Some supportive evidence | Mostly ubiquinone |
| Fertility | An area where ubiquinol research is concentrated | Ubiquinol [6] |
| Multiple system atrophy | One phase 2 trial at 1,500 mg/day | Ubiquinol [6] |
| General healthy ageing | Weak — no outcome trials in healthy adults | — |
That table is the honest frame for the whole form debate. If you are buying CoQ10 as general wellness insurance, you are choosing between two forms of a compound whose strongest evidence lies elsewhere.
This is the most common reason people are told to consider CoQ10, and it deserves a clear-eyed treatment.
Statins inhibit HMG-CoA reductase, an enzyme in the pathway that produces both cholesterol and CoQ10, so statin therapy reduces circulating CoQ10 levels. That much is established biochemistry.
Whether supplementing CoQ10 relieves statin-associated muscle symptoms is less settled — trial results have been mixed, and this remains an area of genuine clinical debate rather than a proven intervention.
Important
If you are experiencing muscle pain on a statin, speak to your GP rather than self-treating. Muscle symptoms need proper assessment — occasionally they indicate a serious problem requiring blood tests. Never stop or reduce a statin because you have started a supplement. Statins have substantial evidence for preventing cardiovascular events; CoQ10 does not replace them, and stopping one carries real risk.
| Your situation | Our read |
|---|---|
| Under 60, general use | Well-formulated ubiquinone softgel. Matches ubiquinol in optimised formulations at a fraction of the cost [1,2] |
| Over 60 | Ubiquinol is a defensible upgrade — the age-stratified absorption data is its strongest evidence [6] |
| Taking it for heart health | Ubiquinone — that is what the outcome trials used, and what an independent review of 28 RCTs recommends [3] |
| Known absorption problems or fat malabsorption | Discuss with your clinician; formulation choice matters more here |
| On a tight budget | Ubiquinone softgel with a fatty meal beats an under-dosed ubiquinol |
| Advised by a cardiologist based on your CoQ10 levels | Follow that advice over any article, including this one |
| Question | Answer |
|---|---|
| Typical dose | 100–200 mg daily; higher doses used in specific clinical research |
| With food? | Always with a meal containing fat [1] |
| Format to prefer | Oil-based softgel over dry powder capsule |
| Timeline | Plasma levels rise over weeks; judge over months |
| Cost difference | Ubiquinol typically around double ubiquinone |
Browse the Welzo ubiquinol collection, heart health supplements, antioxidants and energy and vitality ranges. Related reading: PQQ vs CoQ10 and why supplements are expensive.
CoQ10 has real interactions and this is not a formality:
Seek prompt medical attention for chest pain, breathlessness, palpitations, unexplained severe muscle pain or dark urine. These require assessment, not supplementation. If cardiovascular risk is your concern, a cholesterol blood test, heart disease risk blood test or Full Body MOT Health Check gives you information a supplement cannot.
They are two forms of the same molecule. "CoQ10" usually refers to ubiquinone, the oxidised form; ubiquinol is the reduced form, two hydrogen atoms heavier. They are interconvertible, and your body moves between them continuously. Around 90% of circulating CoQ10 ends up in the ubiquinol form regardless of which you take [1].
Sometimes, but less reliably than the marketing suggests. Studies in older adults have shown ubiquinol producing substantially higher plasma levels [6,7]. But head-to-head work found a solubilised ubiquinone softgel out-absorbing an oil-based ubiquinol softgel, with carrier lipid and solubilisation mattering more than redox form [1,2]. One analysis found ubiquinol's AUC was twice that of a poorly formulated ubiquinone but only 52% of a properly formulated one [1].
For most people under 60, probably not — a well-formulated ubiquinone softgel at an adequate dose taken with fat is likely to serve you as well for roughly half the price. Ubiquinol has a more defensible case if you are over 60, since conversion capacity declines with age and the age-stratified absorption data is its strongest evidence [6].
Ubiquinone, on current evidence. An independent review of 28 randomised controlled trials recommended ubiquinone over ubiquinol for cardiovascular outcomes [3], and the major cardiovascular outcome trials were conducted with ubiquinone formulations [1]. Ubiquinol's trial base is weighted towards absorption and fertility studies rather than hard clinical endpoints [6].
Statins do reduce circulating CoQ10, but whether supplementing relieves statin-associated muscle symptoms remains debated with mixed trial results. Discuss it with your GP rather than self-treating — and never stop or reduce a statin because you have started a supplement. Muscle symptoms on a statin need proper assessment.
Typical supplemental doses are 100–200 mg daily, with higher doses used in specific clinical research contexts. Take it with a meal containing fat, since CoQ10 requires micellarisation with dietary fat for absorption [1]. Splitting larger doses across meals is sensible given the absorption ceiling — oral bioavailability is only around 1–8% regardless of form [1].
On the available evidence, yes. Mantle and Dybring's review found that the absence of CoQ10 crystal dispersion in the initial formulation reduces bioavailability by 75% [1] — a far larger effect than anything reported between redox forms. López-Lluch and colleagues reached the same conclusion comparing seven formulations, finding carrier lipids and solubilisation efficiency drove absorption [2]. None of this appears on a product label, which is the practical problem.
Yes, and this matters. CoQ10 is structurally similar to vitamin K and may reduce the effect of warfarin, so anyone on warfarin should speak to their GP or anticoagulation clinic first. It may also modestly lower blood pressure, compounding with antihypertensives. Discuss with your oncology team if you are having chemotherapy.
In small amounts — organ meats, oily fish, and some nuts and seeds contain it. Dietary intake is typically far below supplemental doses, and CoQ10 is one of the compounds where food alone is unlikely to shift your status meaningfully. That contrasts with, say, butyrate or ergothioneine, where the dietary route is genuinely viable.
Generally yes, and this may matter more than the form debate. A 100 mg ubiquinone softgel with an oil carrier will typically outperform a 100 mg ubiquinol dry powder capsule on absorption, because CoQ10 needs lipid for uptake [1]. If you are choosing between two products, check the format before the redox form.
Medical disclaimer
This article is for general information and does not constitute medical advice, diagnosis or treatment. Food supplements are not a substitute for a varied, balanced diet and a healthy lifestyle, and should not be used to treat or prevent disease. CoQ10 may reduce the effect of warfarin and may lower blood pressure — speak to your GP, pharmacist or anticoagulation clinic before starting if you take these medications. Never stop or reduce a statin or any prescribed cardiovascular medication in favour of a supplement. Muscle pain while taking a statin requires medical assessment. Seek prompt medical attention for chest pain, breathlessness, palpitations, severe unexplained muscle pain or dark urine. Always consult a qualified healthcare professional before starting any new supplement, particularly if you take prescription medication, are undergoing cancer treatment, or are pregnant or breastfeeding. Reviewed for medical accuracy by Dr Zeeshan Afzal. See the full Welzo medical disclaimer.
All product photography in this article is owned by Welzo and served from the Welzo media library. Prices and availability correct at the time of publication and subject to change.
Hodnoceno výborně o 26,523+ recenzí
100% záruka vrácení peněz
Naše záruka vrácení peněz zajišťuje, že obdržíte své položky nebo získáte plnou náhradu.
